Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lucedex: Ranibizumab + Dexamethasone for Wet AMD
NCT00793923Phase 2Completed
- Start
- Jan 2008
- Primary completion
- Jan 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of dexamethasone in exudative age-related macular degeneration. Started Jan 2008; status: completed.
02
Drugs
dexamethasone
03
Conditions
exudative age-related macular degeneration
Beyond the preview
Go deeper on NCT00793923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00793923.